Healthcare Stocks Stable Amid Broad Markets Rise

Dow Jones05:59

Stocks in the healthcare sector were flat amid a broader stock market rise.

Johnson & Johnson raised its full-year guidance on the back of better-than-expected second-quarter earnings as strength in its oncology portfolio helped offset falling sales for its former blockbuster drug, Stelara.

Elevance Health fell 9% although the health insurer beat earnings estimates and boosted its full-year outlook for the second time in months.

Boehringer Ingelheim said its Jardiance diabetes drug helped it increase sales in the first half, as the German drugmaker gears up to file for U.S. approval of a new obesity medicine.

 

Write to Paulo Trevisani at paulo.trevisani@wsj.com

(END) Dow Jones Newswires

July 15, 2026 17:59 ET (21:59 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment